« Back
Home /
Favipiravir

Favipiravir

Manufacturer	TargetMol
Category	Infectious Diseases Viral Infections Coronavirus (COVID-19) Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	5mg
Item no.	TMO-T6833-5mg
CASRN	259793-96-9
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	Favipiravir (T-705), an effective and selective RNA-dependent RNA polymerase inhibitor, are applied to treat influenza virus infections.
Shipping	cool pack
Storage	-20°
Target names or alias	T-705 , 6-Fluoro-3-oxo-3, 4-dihydropyrazine-2-carboxamide
Molecular Weight	157, 1
Pathway	DNA Damage/DNA Repair\|\|\|Microbiology/Virology\|\|\|Cell Cycle/Checkpoint\|\|\|Others
Target	Others\|\|\|DNA/RNA Synthesis\|\|\|Influenza Virus\|\|\|SARS-CoV

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T6833-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5mg

available

Delivery expected until 5/16/2024